Small vessel disease: mechanisms and clinical implications

Joanna M. Wardlaw(University of Edinburgh), Martin Dichgans(Munich Cluster for Systems Neurology), Colin Smith(University of Edinburgh)

The Lancet Neurology

May 13, 2019

10.1016/s1474-4422(19)30079-1

Cited by 1,687

Related Papers

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

|The Lancet Neurology|2013|5.4k

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

|The Lancet|2014|2.7k

National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

|Stroke|2006|1.7k

Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke

|Stroke|2013|1.7k

Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging

|The Lancet Neurology|2013|1.6k